RxDoctor Payments Data

Nelson Nieves, MD

Family Medicine · Davenport, FLNPI 1841327236

Payments from drug & device makers

$508in general payments, 2019–2025

Across 30 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$171
  • Amarin Pharma, Inc.$140
  • Amgen$69
  • Shield Therapeutics Inc$36
  • Abbott$29
  • Eisai Inc.$26
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$508100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$508 in reported general payments places this provider in the 50th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$68,091
Medicare patients
85
Services billed
617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$84,695
Trelegy ElliptaFluticasone/Umeclidin/Vilanter67$42,343
EliquisApixaban39$29,205
Breo ElliptaFluticasone/Vilanterol47$17,982
JardianceEmpagliflozin23$17,875
JanuviaSitagliptin Phosphate29$17,778
TrulicityDulaglutide12$17,105
Fluticasone-SalmeterolFluticasone Propion/Salmeterol114$13,019
LinzessLinaclotide23$11,775
XareltoRivaroxaban20$11,769
Janumet XrSitagliptin Phos/Metformin Hcl13$10,830
RybelsusSemaglutide11$10,715
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$7,112
MyrbetriqMirabegron15$6,331
Lantus SolostarInsulin Glargine,hum.Rec.Anlog60$5,564

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$17$17,87523 claims
Lilly USA, LLCTrulicity$171$17,10512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Davenport

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →